Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy

Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
Published at www.nejm.org February 17, 2010 (10.1056/NEJMp1001578)

Worthwhile read not only for the interesting potential link between this medication and medullary thyroid cancer, but also a look at what goes into the approval process for new diabetic medications.